Cargando…
Establishment of two oxaliplatin-resistant gallbladder cancer cell lines and comprehensive analysis of dysregulated genes
Acquired resistance to chemotherapeutic drugs in gallbladder cancer (GBC) results in therapy failure. This study is aimed to establish oxaliplatin (OXA)-resistant GBC cell lines and uncover their gene expression profiles. First, two OXA-resistant GBC cell lines (GBC-SD/OXA and SGC996/OXA) were estab...
Autores principales: | Guo, Haijun, Zhi, Yunqing, Wang, Kaijing, Li, Na, Yu, Danlei, Ji, Zhonghua, Chen, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541806/ https://www.ncbi.nlm.nih.gov/pubmed/37786776 http://dx.doi.org/10.1515/med-2023-0690 |
Ejemplares similares
-
Acquired resistance to oxaliplatin is not directly associated with increased resistance to DNA damage in SK-N-AS(r)OXALI(4000), a newly established oxaliplatin-resistant sub-line of the neuroblastoma cell line SK-N-AS
por: Saintas, Emily, et al.
Publicado: (2017) -
Establishment and characterization of an immortalized epithelial cell line from human gallbladder
por: Wang, Ziyi, et al.
Publicado: (2022) -
A Multicenter Phase II Trial of Gemcitabine Plus Oxaliplatin in Unresectable Gallbladder Cancer
por: Woo, Sang Myung, et al.
Publicado: (2013) -
Establishment and characterization of patient-derived primary cell lines as preclinical models for gallbladder carcinoma
por: Feng, Feiling, et al.
Publicado: (2020) -
Gemcitabine, oxaliplatin and 5-FU in advanced bile duct and gallbladder carcinoma: two parallel, multicentre phase-II trials
por: Wagner, A D, et al.
Publicado: (2009)